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Abstract
Purpose Urological and sexual dysfunction are recognised
risks of rectal cancer surgery; however, there is limited evi-
dence regarding urogenital function comparing robotic to lap-
aroscopic techniques. The aim of this study was to assess the
urogenital functional outcomes of patients undergoing laparo-
scopic and robotic rectal cancer surgery.
Methods Urological and sexual functions were assessed using
gender-specific validated standardised questionnaires.
Questionnaires were sent a minimum of 6 months after sur-
gery, and patients were asked to report their urogenital func-
tion pre- and post-operatively, allowing changes in urogenital
function to be identified. Questionnaires were sent to 158
patients (89 laparoscopy, 69 robotic) of whom 126 (80 %)
responded. Seventy-eight (49 male, 29 female) of the re-
sponders underwent laparoscopic and 48 (35 male, 13 female)
robotic surgery.
Results Male patients in the robotic group deteriorated less
across all components of sexual function and in five compo-
nents of urological function. Composite male urological and
sexual function score changes from baseline were better in the
robotic cohort (p < 0.001). In females, there was no difference
between the two groups in any of the components of urologi-
cal or sexual function. However, composite female urological
function score change from baseline was better in the robotic
group (p = 0.003).
Conclusion Robotic rectal cancer surgery might offer better
post-operative urological and sexual outcomes compared to
laparoscopic surgery in male patients and better urological
outcomes in females. Larger scale, prospective randomised
control studies including urodynamic assessment of urogeni-
tal function are required to validate these results.
Keywords Robotic surgery . Rectal cancer . Urogenital
function . Urological function . Sexual function
Introduction
Rectal cancer surgery is associated with a high risk of urologi-
cal and sexual dysfunction which significantly affects the
quality of life of its survivors [1–6]. Although urogenital dys-
function is thought to be multifactorial in nature, intra-
operative damage to the autonomic pelvic nerves is consid-
ered to be the primary cause [5–7].
It is argued that better visualisation of the pelvic autonomic
nerves such as obtained during minimally invasive surgery
could enable the preservation of these structures and therefore
reduce the incidence of urogenital dysfunction [8]. However,
despite laparoscopic total mesorectal excision (TME) becom-
ing the standard approach in much of the modern world, it is
still debated whether it has helped improve urogenital dys-
function. In fact, the evidence comparing the urogenital out-
comes of open and laparoscopic TME is conflicting, with
some studies advocating favourable urogenital outcomes for
laparoscopic TME [9] whilst others for open TME [10]. A
recently published systematic review concluded that neither
approach is superior in terms of urogenital preservation [11].
A probable explanation for this is that laparoscopic rectal
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surgery is technically difficult [12]. Existing laparoscopic in-
struments have a restricted range of movement compared with
those of the surgeons’ hand and are difficult to use in confined
spaces such as the pelvis [13, 14].
Robotic surgical systems were introduced to overcome the
technical limitations of laparoscopic surgery [15]. With supe-
rior three-dimensional views, tremor filtering and angulated
instruments, robotic surgery enables precise dissection in nar-
row surgical spaces such as the pelvis therefore enabling better
preservation of fine structures such as the autonomic nerves
[13, 16]. Currently, there are only a few studies investigating
the urological and sexual outcomes of robotic surgery against
those of laparoscopic surgery and these tend to be predomi-
nant about male patients.
The aim of this retrospective clinical study is to compare
the urological and sexual functional outcomes of robotic and
laparoscopic rectal cancer surgery using a validated functional
questionnaire in both men and women in a high-volume min-
imally invasive colorectal unit. Only one similar study has
been identified and deemed up to date but its sample size is
significantly smaller [17]; therefore, our study aims to build
upon that evidence base.
Methods
All patients who underwent potentially curative elective lapa-
roscopic or robotic rectal cancer resections from December
2006 to September 2009 for the laparoscopic group and from
May 2013 and September 2014 for the robotic group were
identified from a prospectively maintained database. Rectal
cancer was defined as cancer present within 15 cm from the
anal verge. Surgery was performed in both groups by two
surgeons with vast laparoscopic and robotic experience work-
ing in a high-volume minimally invasive colorectal unit.
Urological and sexual function was assessed using gender-
specific validated questionnaires sent a minimum of 6 months
after surgery to allow for wound healing and objective data
collection. Urogenital data for the laparoscopic group was
collected during a previous study comparing the urogenital
outcomes of laparoscopic and open rectal surgery [9].
Urogenital data for the robotic group was collected subse-
quently, when the two performing surgeons adopted its
practice.
Formal oncological and physical assessment was un-
dertaken by all patients prior to surgery following the
protocol. Pre-operative staging was performed by colo-
noscopy or CT colonography, computed tomography
(CT) of the chest and abdomen and magnetic resonance
imaging (MRI) of the pelvis. Patients with low rectal
cancers (5 cm from anal verge) underwent additional
staging with endo-anal ultrasound (EUS).
All patient findings were discussed in the multidisciplinary
team meeting prior to initiating any type of treatment. In gen-
eral, pre-operative long-course chemoradiotherapy was re-
served for T4 rectal cancers or those where the circumferential
resection margin (CRM) appeared threatened on MRI, whilst
short-course radiotherapy was advised for rectal cancers that
approached but did not threaten the CRM. Radiotherapy was
not used where rectal cancers were considered resectable by
TME with a good likelihood of clear margins.
Appropriate approval for the study was obtained by the
Research and Development department of Portsmouth NHS
Trust. Informed consent was also obtained from the patients
participating in this study.
Surgical technique
The laparoscopic group had a standardised technique which
has been previously published [9, 18]. A modular approach of
medial to lateral colonic mobilisation with isolation and liga-
tion of the main vessels using clips was applied, and TMEwas
performed using monopolar diathermy as previously de-
scribed [18].
Robotic rectal resections were performed using a single
docking fully robotic approach [19]. The principle of
standardised technique developed for laparoscopic surgery
was also used for robotic surgery. Procedures commenced
with medial to lateral dissection followed by vascular control
by ligating the main vessels. Hem-o-loks® were used to se-
cure the vessels before division and a three-step approach was
used for splenic mobilisation [20]. TME was performed in the
same stepwise manner as in the laparoscopic group, starting
with posterior mobilisation followed by right lateral, anterior
and left lateral mobilisation in a stepwise manner. Similarly,
robotic dissection was performed using monopolar diathermy.
Post-operatively, all patients were managed using the en-
hanced recovery program described by Kehlet and Wilmore
[21]. Patients were discharged home according to set criteria
for discharge.
Patient selection
No specific selection criteria were used to allocate patients to
laparoscopic or robotic surgery. In this study, two surgeons
performed all laparoscopic and robotic resections. Between
2006 and 2009, laparoscopy was the preferred approach for
rectal surgery, whereas following the adoption of robotic sur-
gery in May 2013, robotic surgery became the surgical ap-
proach of choice for rectal cancers.
Urogenital function assessment
Urogenital function was assessed as described in our previous
study [9]. Anonymous and confidential questionnaires were
Int J Colorectal Dis
sent to all surviving patients in February 2010 for the laparo-
scopic group and in May 2015 for the robotic group, a mini-
mum of 6 months following surgery through the post. Patients
were asked to rate their urological and sexual function pre-
operatively and post-operatively. To maximise patient re-
sponse rate, patients that did not reply to the questionnaires
within 4 weeks were sent a reminder letter.
For male urological function, we used a modification of the
International Prostatic Symptoms Score (IPSS) [22], for male
sexual function the International Index of Erectile Function
(IIEF-5) [23], for female urological function the King’s
Health questionnaire [24] and for female sexual function the
Female Sexual Function Index (FSFI) [25].
The following components were assessed in each
questionnaire:
1. Male urological function (MUF): frequency, nocturia, ur-
gency, straining, poor flow and incomplete bladder
emptying.
2. Male sexual function (MSF): libido, erection, stiffness for
penetration and orgasm/ ejaculation.
3. Female urological function (FUF): frequency, nocturia,
urgency and stress incontinence.
4. Female sexual function (FSF): arousal/ libido, lubrication,
orgasm and dyspareunia.
Overall, there were six components for MUF and four for
MSF, FUF and FSF. Each component was analysed indepen-
dently and a composite score for each questionnaire was cre-
ated by adding the scores of each component. Scoring was
standardised and quantified for all questions. The following
scale was applied: 0 for not at all, 1 for less than half the time,
2 for about half the time, 3 for more than half the time and 4
for almost always. A score of 0 reflected normal function
whilst 4 poor function. Overall, a high score reflected a high
degree of dysfunction whereas a low score reflected normal
function.
Statistical analysis
IBM SPSS version 22 (SPSS Inc., Chicago, IL, USA) and
Microsoft Excel 2010™ were used for the statistical analysis.
Data was expressed as mean ± standard error of the mean and
median with interquartile range for parametric and non-
parametric data, respectively. Baseline demographic and clin-
ical characteristics were compared using the χ2 test or Fisher’s
exact test for categorical variables and the t test or Mann-
WhitneyU test for continuous variables. Urogenital functional
scores were compared using a t test. p values of <0.05 were
considered statistically significant. Sexually inactive patients
were excluded from the sexual outcome analysis to avoid
skewing of the data.
Results
Patient characteristics
Questionnaires were sent to 158 patients (89 laparoscopic
group, 69 robotic) of whom 126 (80 %) responded. Seventy-
eight (49 male, 29 female) of the responders underwent lapa-
roscopic and 48 (35 male, 13 female) robotic surgery. Of
those, 45 patients (36 male, 9 female) were sexually active
in the laparoscopic group and 17 (13 male, 4 female) in the
robotic group.
The demographic, clinical and pathological characteristics
of the patients included in this study are summarised in
Table 1. The baseline characteristics of the two groups were
broadly comparable. Nevertheless, patients in the robotic
group had lower rectal cancers (p = 0.032) and were more
likely to receive long-course pre-operative radiotherapy
(p = 0.012) and neoadjuvant chemotherapy (p = 0.030).
Male urological function
There were 49 patients in the laparoscopic group and 35 in the
robotic group. In Tables 2 and 3 and Fig. 1, we present the
mean pre-operative MUF scores and their change from base-
line. Pre-operative urological function was worse across three
components (frequency, nocturia, urgency) in the robotic
group, and the pre-operative composite mean MUF score
was worse in the robotic group.
Mean score change from baseline was better in all except
one component (initiation/ straining) in the robotic group (see
Table 2). Composite mean MUF score change from baseline
was also better in the robotic group as illustrated in Table 3
and Fig. 1. Overall, composite mean MUF scores deteriorated
in the laparoscopic group and improved in the robotic group
(p < 0.001, p = 0.023), Table 3.
Male sexual function (MSF)
There were 36 patients (73 %) in the laparoscopic group and
13 (37 %) in the robotic group who were sexually active. Pre-
operative scores were similar in both groups. In Tables 4 and 5
and Fig. 1, we present the mean pre-operative MSF scores and
their change from baseline.
Mean scores deteriorated across all component of
MSF in the laparoscopic group but none in the robotic
group. Statistical comparison of the mean change of
MSF scores from baseline revealed favourable outcomes
for the robotic group across all four components of
MSF as shown in Table 4. Composite MSF score
change was also better in the robotic group as illustrat-
ed in Table 5 and Fig. 1.
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Female urological function
There were 29 patients in the laparoscopic group and 13
in the robotic group. The mean pre-operative FUF
scores of both groups are shown in Tables 6 and 7.
Pre-operative scores were similar in both groups across
all components.
The mean FUF score changes from baseline are
outlined in Tables 6 and 7 and illustrated in Fig. 1.
There was no statistical difference in any of the mean
FUF component score change from baseline between the
two groups. However, composite mean FUF score
change from baseline was better in the robotic group.
Composite mean FUF score deteriorated in the laparo-
scopic group but not in the robotic group (see Table 7).
Female sexual function
There were nine (31 %) sexually active patients in the laparo-
scopic group and four (31 %) in the robotic group. Their pre-
operative scores were similar in both groups as shown in
Tables 8 and 9.
Mean FSF score changes from baseline are outlined in
Tables 8 and 9 and Fig. 1. Overall, there was no statistical
difference between the mean change of scores from baseline
between the two groups in any of the FSF components or the
FSF composite scores.
Table 2 Baseline and change from baseline MUF mean scores
(mean ± standard error of the mean)
Laparoscopic Robotic p value
Baseline MUF
•Frequency 1.63 2.51 0.013
•Nocturia 2.06 2.91 0.013
•Urgency 0.59 1.63 0.003
•Initiation/straining 0.16 0.26 0.576
•Poor flow 0.69 1.26 0.090
•Incomplete bladder emptying 0.92 1.20 0.406
Change from baseline
•Frequency 0.57 ± 0.16 −0.31 ± 0.22 0.002
•Nocturia 0.63 ± 0.17 −0.20 ± 0.19 0.002
•Urgency 0.69 ± 0.21 −0.66 ± 0.29 <0.001
•Initiation/straining 0.39 ± 0.12 0.09 ± 0.13 0.094
•Poor flow 0.73 ± 0.18 −0.14 ± 0.21 0.002
•Incomplete bladder emptying 0.16 ± 0.20 −0.63 ± 0.26 0.017
Table 3 Mean composite MUF scores
Pre-op Post-op p value Mean score change
Lap 6.06 9.24 <0.001 3.18 ± 0.69
Robotic 9.77 7.69 0.023 −2.14 ± 0.87
p value 0.003 0.229 <0.001
Table 1 Baseline demographic and clinico-pathological features
Laparoscopic Robotic p value
Gender
•Male 49 35 0.243
•Female 29 13
Age
Median (IQR) 70 (63–75.25) 69 (64–74.75) 0.966
BMI median (IQR)
•Male 26 (23–29.5) 27 (25–28.25) 0.275
•Female 26 (24–32.5) 27 (24.25–29.5) 1.000
ASA grade
•1 12 (15 %) 4 (9 %) 0.407
•2 51 (65 %) 39 (85 %) 0.019
•3 15 (19 %) 3 (7 %) 0.066
Type of surgery
❖Total AR 63 (81 %) 40 (84 %) 0.716
•Male AR 38 (76 %) 30 (86 %) 0.409
•Female AR 25 (86 %) 10 (77 %) 0.657
❖Covering ileostomy 56 (89 %) 34 (85 %) 0.562
•Male 36 (95 %) 26 (87 %) 0.394
•Female 20 (80 %) 8 (80 %) 1.000
❖Total APER 14 (18 %) 7 (15 %) 0.623
•Male 10 (20 %) 4 (11 %) 0.377
•Female 4 (14 %) 3 (23 %) 0.657
❖ Total Hartman’s 1 (1 %) 1 (2 %) 1.000
•Male 1 (2 %) 1 (3 %) 1.000
•Female 0 0 1.000
Anal verge mean (SE) 9.36 ± 0.38 7.91 ± 0.54 0.032
T stage
•Tx 4 (5 %) 2 (4 %) 1.000
•T1 6 (8 %) 6 (13 %) 0.372
•T2 26 (33 %) 21 (44 %) 0.240
•T3 36 (46 %) 16 (33 %) 0.156
•T4 6 (8 %) 3 (6 %) 1.000
Radiotherapy
•Pre-op short 9 (12 %) 0 0.014
•Pre-op long 5 (6 %) 11 (23 %) 0.012
•Pre-op total 14 (18 %) 11 (23 %) 0.497
•Post-operative 0 1 (2 %) 0.328
Chemotherapy
•Neoadjuvant 7 (9 %) 11 (23 %) 0.030
•Adjuvant 18 (23 %) 16 (33 %) 0.208
Post-op complications
•Anastomotic leak 3 (4 %) 4 (5 %) 1 (2 %)
•Return to theatre 0 1.000 0.301
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Discussion
Robotic rectal surgery has been gaining popularity over the
last few years. However, whether it is superior to laparoscopic
rectal surgery remains an open debate. In this study, we have
found that the robotic approach offers favourable post-
operative urogenital functional outcomes in men and urologi-
cal outcomes in women. Whilst composite MUF, MSF and
FUF scores deteriorated in the laparoscopic group, this was
not the case for the robotic group. Mean composite score
change from baseline for MUF, MSF and FUF favoured the
robotic group. The functional score change from baseline was
also statistically better in all four components of MSF and in
five out of six components in MUF.
Favourable post-operative male sexual function for robotic
TME as compared to laparoscopic TME has been demonstrat-
ed in previous studies [17, 26–29]. Park et al’s [26] study
showed that MSF recovers faster in the robotic group (6 vs
12months), and at 6 months, the overall MSF scores showed a
significantly smaller decrease from baseline in the robotic
group (p = 0.03). Kim et al. [27], Park et al. [28],
D’Annibale et al. [29] and Morelli et al. [17] all demonstrated
favourable male sexual outcomes for the robotic group but
unlike ours and Park et al’s [26] studies, failed to demonstrate
a change of overall MSF scores from baseline in favour of the
robotic group. It is worth noting that regarding sexual func-
tion, the sample size of these studies was similarly small as to
our study, with the range of patients varying between 20 and
14 in the robotic group and 23 and 15 in the laparoscopic
group. This shows that a relatively small sample size is suffi-
cient to demonstrate the superiority of robotic rectal surgery in
terms of male post-operative sexual function outcomes.
Unlike sexual function, advantages in male urological
function following robotic surgery have been harder to dem-
onstrate. A multitude of studies comparing the MUF of robot-
ic vs laparoscopic patients showed no difference in their out-
comes [17, 28, 29]. In contrast to the above, Cho et al. [30] in a
retrospective study of 278 patients in each group found that at
1 month after surgery, the voiding dysfunction rate was higher
in the laparoscopic group (4.3 vs 0.7 %, p = 0.012). However,
this study did not apply any functional scores for the assess-
ment of dysfunction, leaving it open to observation bias. Park
et al. [26] on a population of 32 patients in each group found
that at 12 months following surgery, MUF score change from
baseline was lower in the robotic group, but this was not quite
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Fig. 1 Change in mean
composite scores from baseline
Table 4 Baseline and change from baseline MSF mean scores
(mean ± standard error of the mean)
Laparoscopic Robotic p value
Baseline MSF
•Sexually active Yes 36, no 13 Yes 13, no 22
•Libido/arousal 0.31 0.54 0.422
•Erection 0.69 0.85 0.712
•Stiffness for penetration 0.86 1.15 0.547
•Orgasm/ejaculation 0.17 0.92 0.057
Change from baseline
•Libido/arousal 1.56 ± 0.28 0 ± 0.30 0.001
•Erection 1.53 ± 0.29 0 ± 0.20 <0.001
•Stiffness for penetration 1.39 ± 0.29 −0.38 ± 0.21 <0.001
•Orgasm/ejaculation 1.78 ± 0.31 −0.15 ± 0.25 <0.001
Table 5 Mean composite MSF scores
Pre-op Post-op p value Mean score change
Lap 2.31 8.56 <0.001 6.25 ± 1.08
Robotic 3.62 2.92 0.759 −0.69 ± 0.85
p value 0.319 0.004 <0.001
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statistically significant (p = 0.051). However, Kim et al. re-
ported a clear advantage for robotic TME in terms of urologi-
cal function [27]. On a sample size of 30 robotic and 39 lap-
aroscopic patients, they showed that urological function re-
covered faster in the robotic group (3 vs 6 months) and func-
tional score change from baseline was lower in the robotic
group at 3 months (p = 0.036). However, we should note that
for this study, male and female data were combined. Our study
is the first one to demonstrate a significant favourable overall
score change from baseline for the robotic approach in a male
cohort only. This is probably due to our study’s larger sample
size (49 laparoscopic vs 35 robotic).
It is also worth noting that the composite MUF mean score
improved in the robotic group. Obviously, we are not suggest-
ing that robotic rectal surgery might itself improve MUF. We
believe this might have occurred due to a number of factors.
First of all, our study was open to recall bias, since patients
reported their urogenital function retrospectively a minimum
of 6 months after their surgery. It is possible that patients that
did not suffer from any post-operative urological dysfunction
might be more prone to better score their post-operative func-
tion. Furthermore, despite the scores being based on validated
standardised questionnaires, questionnaires themselves are
subjective in nature. Ideally, objective measurement tools such
as urodynamic studies used in Kim et al’s study [27] should be
used in conjunction with questionnaires to increase the valid-
ity of the results.
The results from our study indicate favourable outcomes
following robotic TME in relation to FUF. Present evidence of
FUF following robotic rectal surgery is extremely limited,
with only two studies to date investigating FUF independently
to that of males [17, 31]. Of those two, only one, whose sam-
ple size is considerably smaller, used a control group
(laparoscopy) against its robotic cases and found no difference
in outcome between the two groups [17].
Regarding FSF, there was no difference between the two
groups in any of the individual components or the composite
score. However, due to a large proportion of females being
sexually inactive, the sample size of the FSF comparison was
very small (nine laparoscopic vs four robotic). This makes any
meaningful statistical comparison very difficult. Current evi-
dence on robotic FSF is also extremely limited, being inves-
tigated in only three studies [17, 31, 32] of which only one
used a control group (laparoscopy). In that study, Morelli et al.
[17] found no difference in FSF scores between the two
groups.
Our study is unique as it has the biggest sample size of its
kind. In addition, it is the only study of its kind conducted in
the UK, where patient socio-economic background would
have no influence on the mode of surgery chosen, since all
patients would have been operated in a public healthcare ser-
vice, the NHS.
In contrast to the majority of the previously published lit-
erature, the operating surgeons in our study performed fully
robotic rather than hybrid procedures [19]. It is possible that
the difference in approach could influence the results. This is
because damage to the autonomic nerves could occur in two
Table 8 Baseline and change from baseline FSF mean scores
(mean ± standard error of the mean)
Laparoscopic Robotic p value
Baseline FSF
•Sexually active Yes 9, no 20 Yes 4, no 9
•Arousal/ libido 0.89 1.50 0.589
•Lubrication 1.44 1.25 0.865
•Orgasm 0.44 2.25 0.177
•Dyspareunia 0.44 0.75 0.620
Change from baseline
•Arousal/ libido 0.67 ± 0.37 −0.25 ± 0.25 0.066
•Lubrication 0 ± 0.17 1.25 ± 0.95 0.279
•Orgasm 0.89 ± 0.42 0 ± 0 0.069
•Dyspareunia 0.44 ± 0.47 2 ± 0.82 0.159
Table 6 Baseline and change from baseline FUF mean scores
(mean ± standard error of the mean)
Laparoscopic Robotic p value
Baseline FUF
•Frequency 1.66 2.23 0.325
•Nocturia 1.79 2.85 0.056
•Urgency 0.76 1.46 0.190
•Stress incontinence 1.10 1.92 0.143
Change from baseline
•Frequency 0.62 ± 0.25 −0.54 ± 0.56 0.077
•Nocturia 0.69 ± 0.27 0.38 ± 0.40 0.533
•Urgency 0.48 ± 0.16 −0.15 ± 0.27 0.059
•Stress incontinence 0.10 ± 0.11 −0.23 ± 0.28 0.287
Table 7 Mean composite FUF scores
Pre-op Post-op p value Mean score change
Lap 5.31 7.21 <0.001 1.90 ± 0.50
Robotic 8.46 6.23 0.065 −2.23 ± 1.10
p value 0.052 0.501 0.003
Table 9 Mean composite FSF scores
Pre-op Post-op p value Mean score change
Lap 3.22 5.22 0.154 2 ± 1.27
Robotic 5.75 8.75 0.181 3 ± 1.73
p value 0.251 0.269 0.657
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places where dissection is performed laparoscopically during
the hybrid procedure. The superior hypogastric plexus can be
damaged during dissection around the inferior mesenteric ar-
tery pedicle and the hypogastric nerves during mobilisation of
the rectosigmoid colon from the gonadals and the ureter [4,
33]. Therefore, in our study, we exploit the full potential of the
robotic approach.
In addition, all the procedures in both the laparoscopic and
robotic cohort were performed by the same two surgeons, thus
eliminating the confounding factor of the operating surgeon.
Moreover, all the laparoscopic procedures pre-dated the robot-
ic ones, since the operating surgeons shifted their regular prac-
tice from laparoscopic to robotic TMEs. It could be argued
that any skills acquired during the laparoscopic procedures
were transferrable to the robotic ones, implying that any su-
periority demonstrated for the robotic group was not a result of
the surgical approach but due to the advancement of the sur-
geon’s skills. However, this is unlikely considering both sur-
geons were very experienced laparoscopic rectal surgeons that
were trainers for the National Training Programme for
Laparoscopic Colorectal Surgery (LAPCO) in the UK.
We acknowledge this study is retrospective and non-
randomised in nature. However, despite the lack of
randomisation, our results demonstrate from the baseline char-
acteristics that the two groups were broadly comparable. The
only differences between the two groups (tumour high, neo-
adjuvant radiotherapy and chemotherapy) are more likely to
negatively skew the results against the robotic group, since
long-course radiotherapy and lower rectal tumours possess
risks for urogenital dysfunction.
A limitation of our study was that post-operative urogenital
function reporting was taken as a Bsnapshot^, with patients
reporting their urogenital outcomes only once in a post-
operative period varying from 6 months to 3 years in the
laparoscopic group and 8 months to 2 years to in the robotic
group. However, unlike other studies, this study does not
make any assumptions on the time of recovery of urogenital
function but only on the overall post-operative urogenital
outcomes.
In summary, our study has demonstrated that robotic
rectal cancer surgery might offer favourable overall post-
operative urological and sexual outcomes in males and
urological outcomes in females. This is probably because
robotic systems allow for precise dissection across the
surgical planes in narrow spaces such as the pelvis, thus
enabling preservation of the pelvic autonomic nerves. We
acknowledge that there are limitations in the study’s de-
sign such as being retrospective in nature and open to
recall bias. We believe a prospective randomised control
trial, focusing on urogenital function, with a bigger sample
size that includes urodynamic assessment of urological
function is required to establish whether robotic surgery
truly offers superior post-operative urogenital outcomes.
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